Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials

Summary: Background: Testing men for HIV during their partner's pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HI...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wilbroad Mutale, MBChB, Kellie Freeborn, PhD, Lauren A Graybill, MSc, Mildred M Lusaka, MSc, Katie R Mollan, MS, Oliver Mweemba, PhD, Margaret Kasaro, MBChB, Rose Lungu, BPA, Andrew Kumwenda, MBChB, Friday Saidi, MBBS, Kimberly A Powers, PhD, Suzanne Maman, PhD, Nora E Rosenberg, PhD, Benjamin H Chi, MD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/4c03faf2e3824dae9759782313958234
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c03faf2e3824dae9759782313958234
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic Public aspects of medicine
RA1-1270
spellingShingle Public aspects of medicine
RA1-1270
Wilbroad Mutale, MBChB
Kellie Freeborn, PhD
Lauren A Graybill, MSc
Mildred M Lusaka, MSc
Katie R Mollan, MS
Oliver Mweemba, PhD
Margaret Kasaro, MBChB
Rose Lungu, BPA
Andrew Kumwenda, MBChB
Friday Saidi, MBBS
Kimberly A Powers, PhD
Suzanne Maman, PhD
Nora E Rosenberg, PhD
Benjamin H Chi, MD
Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials
description Summary: Background: Testing men for HIV during their partner's pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative pregnant women. Methods: We did two parallel, unmasked randomised trials, enrolling pregnant women who had an HIV-positive test result documented in their antenatal record (trial 1) and women who had an HIV-negative test result documented in their antenatal record (trial 2) from an antenatal setting in Lusaka, Zambia. Women in both trials were randomly assigned (1:1) to the intervention or control groups using permuted block randomisation. The control groups received partner notification services only, including an adapted version for women who were HIV-negative; the intervention groups additionally received targeted education on the use of oral HIV self-test kits for their partners, along with up to five oral HIV self-test kits. At the 30 day follow-up we collected information from pregnant women about their primary male partner's HIV testing in the previous 30 days at health-care facilities, at home, or at any other facility. Our primary outcome was reported male partner testing at a health facility within 30 days following randomisation using a complete-case approach. Women also reported male partner HIV testing of any kind (including self-testing at home) that occurred within 30 days. Randomisation groups were compared via probability difference with a corresponding Wald-based 95% CI. The trial is registered at ClinicalTrials.gov (NCT04124536) and all enrolment and follow-up has been completed. Findings: From Oct 28, 2019, to May 26, 2020, 116 women who were HIV-positive (trial 1) and 210 women who were HIV-negative (trial 2) were enrolled and randomly assigned to study groups. Retention at 30 days was 100 (86%) in trial 1 and 200 (95%) in trial 2. Women in the intervention group were less likely to report facility-based male partner HIV testing in trial 1 (3 [6%] of 47 vs 15 [28%] of 53, estimated probability difference –21·9% [95% CI –35·9 to –7·9%]) and trial 2 (3 [3%] of 102 vs 33 [34%] of 98, estimated probability difference –30·7% [95% CI –40·6 to –20·8]). However, reported male partner HIV testing of any kind was higher in the intervention group than in the control group in trial 1 (36 [77%] of 47 vs 19 [36%] of 53, estimated probability difference 40·7% [95% CI 23·0 to 58·4%]) and trial 2 (80 [78%] of 102 vs 54 [55%] of 98, estimated probability difference 23·3% [95% CI 10·7 to 36·0%]) due to increased use of HIV self-testing. Overall, 14 male partners tested HIV-positive. Across the two trials, three cases of intimate partner violence were reported (two in the control groups and one in the intervention groups). Interpretation: Our combination approach increased overall HIV testing in male partners of pregnant women but reduced the proportion of men who sought follow-up facility-based testing. This combination approach might reduce linkages to health care, including for HIV prevention, and should be considered in the design of comprehensive HIV programmes. Funding: National Institutes of Health.
format article
author Wilbroad Mutale, MBChB
Kellie Freeborn, PhD
Lauren A Graybill, MSc
Mildred M Lusaka, MSc
Katie R Mollan, MS
Oliver Mweemba, PhD
Margaret Kasaro, MBChB
Rose Lungu, BPA
Andrew Kumwenda, MBChB
Friday Saidi, MBBS
Kimberly A Powers, PhD
Suzanne Maman, PhD
Nora E Rosenberg, PhD
Benjamin H Chi, MD
author_facet Wilbroad Mutale, MBChB
Kellie Freeborn, PhD
Lauren A Graybill, MSc
Mildred M Lusaka, MSc
Katie R Mollan, MS
Oliver Mweemba, PhD
Margaret Kasaro, MBChB
Rose Lungu, BPA
Andrew Kumwenda, MBChB
Friday Saidi, MBBS
Kimberly A Powers, PhD
Suzanne Maman, PhD
Nora E Rosenberg, PhD
Benjamin H Chi, MD
author_sort Wilbroad Mutale, MBChB
title Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials
title_short Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials
title_full Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials
title_fullStr Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials
title_full_unstemmed Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials
title_sort addition of hiv self-test kits to partner notification services to increase hiv testing of male partners of pregnant women in zambia: two parallel randomised trials
publisher Elsevier
publishDate 2021
url https://doaj.org/article/4c03faf2e3824dae9759782313958234
work_keys_str_mv AT wilbroadmutalembchb additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT kelliefreebornphd additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT laurenagraybillmsc additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT mildredmlusakamsc additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT katiermollanms additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT olivermweembaphd additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT margaretkasarombchb additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT roselungubpa additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT andrewkumwendambchb additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT fridaysaidimbbs additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT kimberlyapowersphd additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT suzannemamanphd additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT noraerosenbergphd additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
AT benjaminhchimd additionofhivselftestkitstopartnernotificationservicestoincreasehivtestingofmalepartnersofpregnantwomeninzambiatwoparallelrandomisedtrials
_version_ 1718425038282031104
spelling oai:doaj.org-article:4c03faf2e3824dae97597823139582342021-11-18T04:48:34ZAddition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia: two parallel randomised trials2214-109X10.1016/S2214-109X(21)00393-4https://doaj.org/article/4c03faf2e3824dae97597823139582342021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2214109X21003934https://doaj.org/toc/2214-109XSummary: Background: Testing men for HIV during their partner's pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative pregnant women. Methods: We did two parallel, unmasked randomised trials, enrolling pregnant women who had an HIV-positive test result documented in their antenatal record (trial 1) and women who had an HIV-negative test result documented in their antenatal record (trial 2) from an antenatal setting in Lusaka, Zambia. Women in both trials were randomly assigned (1:1) to the intervention or control groups using permuted block randomisation. The control groups received partner notification services only, including an adapted version for women who were HIV-negative; the intervention groups additionally received targeted education on the use of oral HIV self-test kits for their partners, along with up to five oral HIV self-test kits. At the 30 day follow-up we collected information from pregnant women about their primary male partner's HIV testing in the previous 30 days at health-care facilities, at home, or at any other facility. Our primary outcome was reported male partner testing at a health facility within 30 days following randomisation using a complete-case approach. Women also reported male partner HIV testing of any kind (including self-testing at home) that occurred within 30 days. Randomisation groups were compared via probability difference with a corresponding Wald-based 95% CI. The trial is registered at ClinicalTrials.gov (NCT04124536) and all enrolment and follow-up has been completed. Findings: From Oct 28, 2019, to May 26, 2020, 116 women who were HIV-positive (trial 1) and 210 women who were HIV-negative (trial 2) were enrolled and randomly assigned to study groups. Retention at 30 days was 100 (86%) in trial 1 and 200 (95%) in trial 2. Women in the intervention group were less likely to report facility-based male partner HIV testing in trial 1 (3 [6%] of 47 vs 15 [28%] of 53, estimated probability difference –21·9% [95% CI –35·9 to –7·9%]) and trial 2 (3 [3%] of 102 vs 33 [34%] of 98, estimated probability difference –30·7% [95% CI –40·6 to –20·8]). However, reported male partner HIV testing of any kind was higher in the intervention group than in the control group in trial 1 (36 [77%] of 47 vs 19 [36%] of 53, estimated probability difference 40·7% [95% CI 23·0 to 58·4%]) and trial 2 (80 [78%] of 102 vs 54 [55%] of 98, estimated probability difference 23·3% [95% CI 10·7 to 36·0%]) due to increased use of HIV self-testing. Overall, 14 male partners tested HIV-positive. Across the two trials, three cases of intimate partner violence were reported (two in the control groups and one in the intervention groups). Interpretation: Our combination approach increased overall HIV testing in male partners of pregnant women but reduced the proportion of men who sought follow-up facility-based testing. This combination approach might reduce linkages to health care, including for HIV prevention, and should be considered in the design of comprehensive HIV programmes. Funding: National Institutes of Health.Wilbroad Mutale, MBChBKellie Freeborn, PhDLauren A Graybill, MScMildred M Lusaka, MScKatie R Mollan, MSOliver Mweemba, PhDMargaret Kasaro, MBChBRose Lungu, BPAAndrew Kumwenda, MBChBFriday Saidi, MBBSKimberly A Powers, PhDSuzanne Maman, PhDNora E Rosenberg, PhDBenjamin H Chi, MDElsevierarticlePublic aspects of medicineRA1-1270ENThe Lancet Global Health, Vol 9, Iss 12, Pp e1719-e1729 (2021)